Cardiovascular Biomarkers: Players, products and prospects (Volume III)

Summary

Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cardiovascular biomarker sector, along with a critical assessment of the companies involved.

Contents

• Executive Summary
  • Figure1: Growth In Biomarker Market 2007-2015
• What Are Biomarkers?
• Why Are They Important?
  • Figure 2: Potential Impact Of Biomarkers On Disease Pathways
• What Technologies Are Involved?
• What Impact Will Biomarkers Have On R&d?
  • Figure 3: Potential Impact Of Biomarkers On R&d
• Who Are The Major Biomarker Players And In What Research Area?
• Cancer Biomarker Companies
• Cardiovascular Biomarker Companies
• Cns Biomarkers Companies
• Company Analysis Criteria
• Biomarker Technology & Platforms
• Association/Clinical Studies
  • Management Strategy
• Application & Potential
• Cardiovascular Market & Revenues
  • Market Revenues - Global
    • Figure 1: Global Cardiovascular Disease Drug Sales 2007
  • Market Revenues - Leading Brands
    • Figure 2: Leading Cardiovascular Brands (2007)
  • Market Revenues - Leading Players
    • Figure 3: Top 10 Cardiovascular Players (2007 Revenues)
• Cardiovascular Epidemiology, Diagnosis, Screening & Treatment
  • Epidemiology
    • Figure 4: Breakdown Of Deaths From Cardiovascular Diseases In The Us (2004)
  • Diagnosis
  • Screening
    • Table 1: Screening For Cardiovascular Disease
  • Current Treatments
    • Table 2: Cardiovascular Therapeutic Drug Categories And Their Indications
  • Future Treatments
    • Figure 5: Drugs In Clinical Development For Heart Disease
  • Cardiovascular Biomarkers
  • Cardiovascular Biomarker R&d
    • Figure 6: Impact Of Biomarkers On The Drug R&d Process
    • Table 3: Types Of Biomarker
  • Known Cardiovascular Biomarkers
    • Table 4: Commercially Available Cardiovascular Diagnostics
  • Probable And Possible Valid Cardiovascular Biomarkers
    • Table 5: Probable Cardiovascular Biomarkers
    • Table 6: Possible Cardiovascular Biomarkers
• Cardiovascular Biomarker Opportunities & Challenges
  • Opportunities
    • Figure 7: Cardiovascular Biomarker Opportunities
  • Challenges
    • Figure 8: Cardiovascular Biomarker Challenges
• Biomarker Market
  • Cardiovascular Biomarkers: Players, Products And Prospects
  • Biomarker Market Revenues - Global
    • Figure 9: Global Biomarker Sales In 2007
  • Cardiovascular Biomarker Market Revenues - Global
    • Figure 10: Global Cardiovascular Biomarker Sales In 2007
  • Future Biomarker Market Revenues - Global
    • Figure 11: Global Biomarker Sales In 2015
  • Future Cardiovascular Biomarker Market Revenues - Global
    • Figure 12: Global Cardiovascular Biomarker Sales In 2015
• Cardiovascular Biomarker Trends
  • Table 7: Recent Deals In Cardiovascular Biomarkers
• Pharma And Specialty Pharma Deals
• Collaborations With Service Providers
• Collaborations With Academics And Consortia
• Biomarker Analysis
  • Assays For Circulating Biomarkers
  • Dna And Rna Biomarkers
  • Proteomic, Metabolomic Biomarkers
  • Systems Biology For Biomarker Discovery
  • Imaging Biomarkers
• Key Biomarker Companies Analysed
• Key Biomarker Evaluation Criteria
• Cardiovascular Biomarkers - Company Analysis
• Abbott Diagnostics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Atherotech
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Affymetrix
  • Biomarker Novelty & Technology Platform
  • Figure 13: Affymetrix'' Approach To Biomarker Discovery, Validation And Clinical Utility Applications
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Beckman Coulter
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Berkeley Heartlab
  • Biomarker Novelty & Technology Platform
  • Figure 14: Markers Of Cardiovascular Disease Measured At Berkeley Heartlab
  • Association Studies/Clinical Data
  • Table Of Contents
• Cardiovascular Biomarkers: Players, Products And Prospects
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Bg Medicine
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Figure 15: Bg Medicine''s Biomarker Programme
  • Application & Market Potential
  • Biomarker Analysis
• Cardiodx
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
  • Competitor Ratio Analysis Score = 9/40
• Celera
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Cis Biotech
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Clinical Data
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Compugen
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Critical Diagnostics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Decode Genetics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Table Of Contents
  • Cardiovascular Biomarkers: Players, Products And Prospects
  • Figure 16: Decode''s Approach To Target Discovery And Development
  • Application & Market Potential
  • Biomarker Analysis
• Diadexus
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Entelos
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Foxhollow Technologies
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Ge Healthcare
  • Biomarker Novelty & Technology Platform
  • Figure 17: Cardiology Focus At Ge Healthcare
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Genomas
  • Biomarker Novelty & Technology Platform
  • Figure 18: Physiogenomics Technology From Genomas
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Inverness Medical Innovations
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Jurilab
  • Biomarker Novelty & Technology Platform
  • Figure 19: Jurilab''s Genetic Discovery Method
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
  • Competitor Ratio Analysis Score = 12/40
  • Laboratory Corporation Of America
  • Biomarker Novelty & Technology Platform
  • Table Of Contents
• Cardiovascular Biomarkers: Players, Products And Prospects
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Lipomics Technologies
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Liposcience
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Competitor Ratio Analysis Score = 15/40
• Nanosphere Inc
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Osmetech Molecular Diagnostics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Competitor Ratio Analysis Score = 12/40
• Prognostix
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Quest Diagnostics
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Competitor Ratio Analysis Score = 27/40
• Roche Diagnostics
  • Biomarker Novelty & Technology Platform
  • Figure 20: Roche''s Technologies For Biomarker Discovery And Development
  • Association Studies/Clinical Data
  • Figure 21: Roche''s Clinical Trial Programme For Cardiac Biomarker Nt-Probnp
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
  • Table Of Contents
• Cardiovascular Biomarkers: Players, Products And Prospects
• Siemens Medical Solutions
  • Biomarker Novelty & Technology Platform
  • Figure 22: Siemens Integrated In Vivo & In Vitro Diagnostic Suites
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Singulex
  • Biomarker Novelty & Technology Platform
  • Figure 23: Sensitivity Of Singulex''s Erenna System Compared To Elisa And Bead-Based Fluorescence Readout Systems
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Superarray Bioscience Corporation
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Vermillion
  • Biomarker Novelty & Technology Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Zora Biosciences Oy
  • Biomarker Novelty & Technology Platform
  • Table 8: Zora Metabolite Profiling Platform
  • Association Studies/Clinical Data
  • Management Strategy
  • Application & Market Potential
  • Biomarker Analysis
• Cardiovascular Biomarker Appendix 1
  • Table 9: Global Biomarker Sales 2007-20015e
• Cardiovascular Biomarker Appendix 2
  • Table 10: Global Cardiovascular Biomarker Sales 2007-20015e
• Cardiovascular Biomarker Appendix 3
• Company Analysis Criteria
• Biomarker Technology & Platforms
• Association Studies
  • Management Strategy
• Application & Potential
  • Table 9: Key Cardiovascular Biomarker Companies
  • Figure 26: Leading Cardiovascular Biomarker Companies - Service Providers, Technology Providers, Biomarker Discovery & Diagnostic Developers
• Glossary
• Acronyms
• Bibliography & End Notes